DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO. Stock

Certificat

DE000MG1B3A8

Market Closed - Börse Stuttgart 03:05:26 2024-05-31 pm EDT
206 EUR +1.43% Intraday chart for DISCOUNT ZERTIFIKAT - BECTON DICKINSON AND CO.
Current month-2.15%
1 month-2.15%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 206 +1.43%
24-05-30 203.2 -0.01%
24-05-29 203.2 -0.77%
24-05-28 204.7 +0.06%
24-05-27 204.6 -0.06%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:05 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG1B3A
ISINDE000MG1B3A8
Date issued 2024-04-02
Maturity 2025-03-21 (294 Days)
Parity 1 : 1
Emission price 217.7
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 214.4
Lowest since issue 202
Spread 0.08
Spread %0.04%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus